158 related articles for article (PubMed ID: 37269482)
1. Sweroside alleviates hepatic steatosis in part by activating AMPK/mTOR-mediated autophagy in mice.
Ding Y; Chen Y; Hu K; Yang Q; Li Y; Huang M
J Cell Biochem; 2023 Jul; 124(7):1012-1022. PubMed ID: 37269482
[TBL] [Abstract][Full Text] [Related]
2. Neuregulin 4 alleviates hepatic steatosis via activating AMPK/mTOR-mediated autophagy in aged mice fed a high fat diet.
Zhu B; Mei W; Jiao T; Yang S; Xu X; Yu H; Ding Y; Guo S; Meng B; Zhao L; He M; Dong K; Guo H; Guo X; Zhang H; Dang R; Xiang G; Wen N
Eur J Pharmacol; 2020 Oct; 884():173350. PubMed ID: 32726654
[TBL] [Abstract][Full Text] [Related]
3. GLP-1 analogue improves hepatic lipid accumulation by inducing autophagy via AMPK/mTOR pathway.
He Q; Sha S; Sun L; Zhang J; Dong M
Biochem Biophys Res Commun; 2016 Aug; 476(4):196-203. PubMed ID: 27208776
[TBL] [Abstract][Full Text] [Related]
4. Schisandrin B mitigates hepatic steatosis and promotes fatty acid oxidation by inducing autophagy through AMPK/mTOR signaling pathway.
Yan LS; Zhang SF; Luo G; Cheng BC; Zhang C; Wang YW; Qiu XY; Zhou XH; Wang QG; Song XL; Pan SY; Zhang Y
Metabolism; 2022 Jun; 131():155200. PubMed ID: 35405150
[TBL] [Abstract][Full Text] [Related]
5. Vine tea total flavonoids activate the AMPK/mTOR pathway to amelioration hepatic steatosis in mice fed a high-fat diet.
Wang C; Yang F; Zeng W; Chen X; Qiu Z; Wang Q; Meng Y; Zheng G; Hu J
J Food Sci; 2024 May; 89(5):3019-3036. PubMed ID: 38517018
[TBL] [Abstract][Full Text] [Related]
6. Exogenous galanin alleviates hepatic steatosis by promoting autophagy via the AMPK-mTOR pathway.
Zhu S; Wang S; Luo T
Arch Biochem Biophys; 2023 Aug; 744():109689. PubMed ID: 37429535
[TBL] [Abstract][Full Text] [Related]
7. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone attenuates hepatic lipid accumulation by inducing autophagy via AMPK/mTOR/ULK1-dependent pathway in nonalcoholic fatty liver disease.
Zhang D; Zhang Y; Wang Z; Lei L
Phytother Res; 2023 Mar; 37(3):781-797. PubMed ID: 36479746
[TBL] [Abstract][Full Text] [Related]
9. Effect of vitamin D
Lim H; Lee H; Lim Y
Exp Biol Med (Maywood); 2021 May; 246(10):1139-1147. PubMed ID: 33541129
[TBL] [Abstract][Full Text] [Related]
10. Red Pepper Seeds Inhibit Hepatic Lipid Accumulation by Inducing Autophagy via AMPK Activation.
Lee YH; Kim HJ; You M; Kim HA
Nutrients; 2022 Oct; 14(20):. PubMed ID: 36296933
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-38 alleviates hepatic steatosis through AMPK/autophagy-mediated suppression of endoplasmic reticulum stress in obesity models.
Sun JL; Cho W; Oh H; Abd El-Aty AM; Hong SA; Jeong JH; Jung TW
J Cell Physiol; 2024 Apr; 239(4):e31184. PubMed ID: 38197464
[TBL] [Abstract][Full Text] [Related]
12. Acetaminophen aggravates fat accumulation in NAFLD by inhibiting autophagy via the AMPK/mTOR pathway.
Shi C; Xue W; Han B; Yang F; Yin Y; Hu C
Eur J Pharmacol; 2019 May; 850():15-22. PubMed ID: 30753863
[TBL] [Abstract][Full Text] [Related]
13. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR.
Zhang CY; Tan XH; Yang HH; Jin L; Hong JR; Zhou Y; Huang XT
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897843
[TBL] [Abstract][Full Text] [Related]
14. γ-Linolenic Acid Prevents Lipid Metabolism Disorder in Palmitic Acid-Treated Alpha Mouse Liver-12 Cells by Balancing Autophagy and Apoptosis via the LKB1-AMPK-mTOR Pathway.
Liang Y; Zhang Z; Tu J; Wang Z; Gao X; Deng K; El-Samahy MA; You P; Fan Y; Wang F
J Agric Food Chem; 2021 Jul; 69(29):8257-8267. PubMed ID: 34281337
[TBL] [Abstract][Full Text] [Related]
15. Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK-mTOR-SREBP signaling pathway.
Quan HY; Kim DY; Kim SJ; Jo HK; Kim GW; Chung SH
Biochem Pharmacol; 2013 May; 85(9):1330-40. PubMed ID: 23435355
[TBL] [Abstract][Full Text] [Related]
16. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
17. Resolvin D3 improves the impairment of insulin signaling in skeletal muscle and nonalcoholic fatty liver disease through AMPK/autophagy-associated attenuation of ER stress.
Oh H; Cho W; Abd El-Aty AM; Bayram C; Jeong JH; Jung TW
Biochem Pharmacol; 2022 Sep; 203():115203. PubMed ID: 35948170
[TBL] [Abstract][Full Text] [Related]
18. Dihydromyricetin ameliorates hepatic steatosis and insulin resistance via AMPK/PGC-1α and PPARα-mediated autophagy pathway.
Yang Y; Qiu W; Xiao J; Sun J; Ren X; Jiang L
J Transl Med; 2024 Mar; 22(1):309. PubMed ID: 38532480
[TBL] [Abstract][Full Text] [Related]
19. FNDC5 Alleviates Hepatosteatosis by Restoring AMPK/mTOR-Mediated Autophagy, Fatty Acid Oxidation, and Lipogenesis in Mice.
Liu TY; Xiong XQ; Ren XS; Zhao MX; Shi CX; Wang JJ; Zhou YB; Zhang F; Han Y; Gao XY; Chen Q; Li YH; Kang YM; Zhu GQ
Diabetes; 2016 Nov; 65(11):3262-3275. PubMed ID: 27504012
[TBL] [Abstract][Full Text] [Related]
20. ApoE deficiency promotes non-alcoholic fatty liver disease in mice via impeding AMPK/mTOR mediated autophagy.
Lu W; Mei J; Yang J; Wu Z; Liu J; Miao P; Chen Y; Wen Z; Zhao Z; Kong H; Wu C; Yang Y; Chen M
Life Sci; 2020 Jul; 252():117601. PubMed ID: 32304762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
